Pubblicazioni Scientifiche
Dermatologia14 apr 2025
Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia
Literature about trichoscopy of permanent chemotherapy-induced alopecia
14 apr 2025
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors
Limited data exist on the comparative risk of infections during biologic and Janus kinase inhibitor (JAKi) treatment for atopic dermatitis (AD) in daily practice
14 apr 2025
Passive versus active educational interventions for nevus and melanoma classification
Patients or family members first notice around 50% of primary melanoma lesions
26 mar 2025
Grover's disease in oncologic patients
Clinicopathologic features and systematic review
26 mar 2025
Neoadjuvant Immunotherapy in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (cSCC) is the second most common type
26 mar 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans
Dermatofibrosarcoma protuberans (DFSP) is a cutaneous fibroblastic tumour that is locally aggressive
05 mar 2025
Hormonal Therapies for Acne
Acne impairs quality of life, often leads to permanent scars, and causes psychological distress
05 mar 2025
Atopic dermatitis
Atopic dermatitis is the most common chronic inflammatory skin disease globally
05 mar 2025
Different Phenotypes of Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder with a heterogeneous phenotype
10 feb 2025
Successful response of upadacitinib
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis
10 feb 2025
Trends in cutaneous melanoma mortality and incidence in EU
Cutaneous melanoma (CM) is the leading cause of skin cancer mortality
10 feb 2025
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe AD
Abrocitinib is a JAK-1 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis
10 feb 2025
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata
ALLEGRO-LT is an ongoing, long-term
24 gen 2025
Characterization of different clinical presentation of Merkel cell carcinomas
Recent studies analyzed the impact of Merkel cell polyomavirus (MCPyV) on the prognosis of Merkel cell carcinoma (MCC) patients
24 gen 2025
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2
This second part of the S2k guidelines is an update of the 2015 S1 European guidelines
15 gen 2025
Efficacy of Alexandrite Laser in the Treatment of Pigmented Actinic Keratoses
Pigmented actinic keratoses (PAKs), a pigmented variant of actinic keratosis
15 gen 2025
Reply to incidence of nonmelanoma skin cancer in patients with vitiligo
Reply to ‘incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream’
15 gen 2025
Systematic review of biologic use for psoriasis in HIV-positive individuals
Psoriasis is a chronic, inflammatory systemic condition mediated by T-lymphocyte activation
04 dic 2024
Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
Ritlecitinib and baricitinib are recently approved systemic treatments for severe alopecia areata (AA)
04 dic 2024
A prospective Real-Life Multicenter Study of Tildrakizumab
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis